
News|Articles|May 1, 2007
First-time generic approvals
First-time generic drug approvals: Nadolol/bendroflumethiazide and ciprofloxacin
Advertisement
Key Points
• First-time generic approvals
Nadolol/bendroflumethiazide tablets, 40/5 mg and 80/5 mg (equiv to Corzide tablets)
IMPAX
Ciprofloxacin extended-release tablets, 500 and 1,000 mg (equiv to Cipro XR tablets)
MYLAN
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access
2
Brukinsa/rituximab cuts progression risk 43% in mantle cell lymphoma
3
New study confirms benefits of GLP-1 drugs in patients with PAD
4
Key Takeaways, Study Limitations, and the Broader Implications of CROWN for Patients, Providers, and Payers
5
































